Quantification of sirolimus and everolimus by immunoassay techniques: Test specificity and cross-reactivity evaluation

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 3, 2008, Pages 585-594

  Pieri, M ^a   Miraglia, N ^a   Gentile, A ^a   Polichetti, G ^a   Castiglia, L ^a   Federico, S ^a   Sabbatini, M ^a   Basile, V ^a   Tarantino, G ^a   Acampora, A ^a   Capone, Domenico ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cross reactivity; Everolimus; Immunoassays; Sirolimus

Indexed keywords

CYCLOSPORIN; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN;

ACCURACY; ADULT; ARTICLE; CALIBRATOR; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CROSS REACTIVITY; DRUG MONITORING; DRUG SPECIFICITY; DRUG STRUCTURE; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MICROPARTICLE ENZYME IMMUNOASSAY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 53749099497     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100311     Document Type: Article

References (17)

1. Morelon E, Mamzer-Bruneel MF, Peraldi MN, Kreis H. Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation. Nephrol Dial Transplant 2001; 16:18-20.
2. Bohler T, Waiser J, Budde K, Lichter S, Jauho A, Fritsche L, Korn A, Neumayer HH. The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation. Transplant Proc 1998; 30:2195-7.
3. Crowe A, Bruelisauer A, Druerr L, Guntz P, Lemaire M. Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats. Drug Metab Dispos 1999; 27:627-32.
4. Dunn C, Croom KF. Everolimus: a review of its use in renal and cardiac transplantation. Drugs 2006; 66:547.
5. Yatscoff R, Boeckx R, Holt DW, et al. Consensus guidelines for therapeutic drug monitoring of rapamycin: report of the consensus panel. Ther Drug Monit 1995; 17:676-80.
6. Starling RC, Hare JM, Hauptman P, McCurry KR, Mayer HW, Kovarik JM, Schmisli H. Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling. Am J Transplant 2004; 4:2126-31.
7. Pieri M, Capone D, Gentile A, Miraglia N, Leo E, Federico S, Basile V, Acampora A. Immunoassay determination of rapamycin: reliability of the method with respect to liquid chromatography mass spectrometric quantification. Clin Transpl 2007; 21: 633-7.
8. Bargnoux AS, Bonardet A, Chong G, Garrigue V, Deleuze S, Dupuy AM, Mourad G, Cristol JP. Evaluation of an immunoassay (Abbott-IMX Analyzer) allowing routine determination of sirolimus: comparison with LC-MS method. Transplant Proc 2006, 38:2352-3.
9. Wilson D, Johnston F, Holt D, et al. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus. Clin Biochem 2006; 39:378-80.
10. Baldelli S, Crippa A, Gabrieli R, Fiocchi R, Perico N, Mertini S, Ottomano C, Cattaneo D. Comparison of the Innofluor® certican assay with HPLC_UV for the determination of everolimus concentrations in heart transplantation. Clin Biochem 2006; 39:1152-9.
11. Salm P, Warnholtz C, Boyd J, Arabshahi L, Marbach P, Taylor P. Evaluation of a fluorescent polarization immunoassay for the whole blood everolimus determination using samples from renal transplant recipients. Clin Biochem 2006; 39:732-8.
12. Johnson RN, Sargon R, Woollard G, Davidson J. An evaluation of the Abbott IMX sirolimus assay in relation to a high-performance liquid chromatography-ultraviolet method. Ann Clin Biochem 2005; 42:394-7.
13. Bouzas L, Tutor JC. Determination of everolimus in whole blood using the Abbott IMx® sirolimus microparticle enzyme immunoassay. Clin Biochem 2007; 40:132-6.
14. US Food and Drug Administration. Center for Drug Evaluation and Research. Guidance for Industry: Bioanalytical Method Validation. 2001; www.fda.gov/cder/guidance/index.htm.
15. Pieri M, Miraglia N, Castiglia L, Genovese G, Basilicata P, Simonelli A, Acampora A. Determination of rapamycin: quantification of the sodiated species by an ion trap mass spectrometer as an alternative to the ammoniated complex analysis by triple quadrupole. Rapid Commun Mass Spectrom 2005; 19:3042-50.
16. Capone D, Gentile A, Polichetti G, et al. Stability of sirolimus and everolimus measured by immunoassay techniques in whole blood samples from kidney transplant patients. Int J Immunopathol Pharmacol 2008; 21:297-307.
17. Eksborg S. Evaluation of method-comparison data. Clin Chem 1981; 27:1311-2.